Pneumo Update Europe 2021 - 8th European Update Congress in Pneumology Virtual, 25 - 26 June 2021
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Pneumo Update Europe 2021
8th European Update Congress in Pneumology
Virtual, 25 – 26 June 2021
Scientific Board
Roland Buhl, Germany
David M.G. Halpin, UK
Walter McNicholas, Ireland
Luca Richeldi, Italy
Honorary Chair
Sylvia Hartl, Austria
www.pneumo-update-europe.eu
GINAL
RI
The Update Concept
O
NG
NI
SU
High Value
AI
TR
P
AL
Highly qualified and reputable speakers provide unbiased
interpretation of the latest study results.
Complete
The entire medical field is covered in 13 sessions. You will be
up-to-date in your speciality within two days. All presentations
will be available to delegates to download for free.
Cutting-edge clinical studies
Only international studies published in peer-reviewed journals during
the past 12 months are presented. No repetition of existing state-of-
the-art knowledge.
Ensured practical relevance
All research results are evaluated by experts and put into perspective for
your clinical and practical work – including clear-cut Take-Home Messages.
Interactivity
Interaction among the participants is part of the concept: there is
plenty of room for livechats and livevotings.
Extensive
Tune into PneumoLive International throughout the year, for cutting-
edge free broadcasts focusing on hot topics, congress reviews and
novel developments.
Next broadcast: Sept. 22, 2021
www.streamed-up/medlive
Scientific Board
Dear Colleagues,
Welcome to the 8th Pneumo Update Europe!
We have been providing high-quality educational meetings for respiratory specialists to learn, interact
and exchange with each other for almost a decade.
Again this year, you can expect a fantastic meeting where over the next 2 days you will receive a
Roland Buhl comprehensive, cutting-edge update of recent developments in the field.
(Germany)
Leading European specialists will provide you with critical analyses of latest research, as well as
recommendations for your daily practice, along with many interaction opportunities … all unbiased
and independent of industry.
Please take the opportunity to participate in the discussions during the lectures, to interact via livevoting
David M. G. Halpin
(UK) and livechat and to view the ePosters online.
And don’t forget to attend the interesting industry-sponsored symposia: Sharing important insights:
What we learnt from COVID-19 (Friday 12:30), Hot Topic: Pneumology Meets Oto-Rhino-
Laryngology (Friday 16:45) and TYPE 2 Inflammation: New Developments in Severe Asthma
Management (Saturday 12:30).
Walter McNicholas
(Ireland) Last, but not least, thank you to our partners who are supporting this event: Boehringer Ingelheim,
Novartis, Sanofi, CSL Behring and AstraZeneca – we couldn‘t do it without you!
Sincerely,
Luca Richeldi
(Italy) Roland Buhl David M. G. Halpin Walter McNicholas Luca Richeldi
Pneumology
KI20246
karger.com/pneumology
Program – June 25, 2021
Welcome 8:50 Break 13:15
Tuberculosis & Emerging Infections Interstitial Lung Diseases
Christoph Lange, Germany Luca Richeldi, Italy
14:00
• Epidemiology 9:00 • Diagnosis
• Prevention • Progression
• Diagnostics
• Treatment Pulmonary Endoscopy
Felix Herth, Germany
Oncology
Johan Vansteenkiste, Belgium • Diagnostic Bronchoscopy
• Cryo-Biopsy 14:45
• Preclinical stage 9:45 • Solitary Pulmonary Nodule
• NSCLC • Endosonography
• SCLC • Interventions in Obstructive Lung Diseases
• Mesothelioma
Break 15:30
Break 10:30
Acute Respiratory Failure & Critical Care
Allergy Paolo Pelosi, Italy
Stephen Durham, UK
• Intubation practices 16:00
• Perennial allergic rhinitis 11:00 • Oxygenation targets
• Chronic sinusitis/nasal polyps • Ventilator weaning
• Allergen immunotherapy Update • Helmet non-invasive ventilation vs. high-flow nasal oxygen
• Passive immunotherapy with monoclonal antibodies for allergy
Industry-sponsored Hot Topic 16:45
Asthma
End of Day 17:30
Roland Buhl, Germany
• COVID-19
• Mild asthma 11:45
• Green inhaler
• Triple therapy
• Severe Asthma
Industry-sponsored Satellite Symposium 12:30
Program – June 26, 2021
Hot Topic: »long-COVID« & Rehabilitation Sleep Disordered Breathing
Sally Singh, UK Walter McNicholas, Ireland
9:00
• Recovery • Obstructive sleep apnoea 14:00
• Rehabilitation Interventions • COPD-OSA overlap
• Obesity hypoventilation syndrome
Thoracic Surgery & Lung Transplantation
Gilbert Massard, Luxembourg Pulmonary Vascular Diseases
9:45 Marc Humbert, France
• Lung transplantation 14:45
• Thoracic surgery • Pulmonary hypertension
Break - ePoster Awards 10:30 End of Event 15:30
COPD I - Co-morbidities, Rehab, Intervention &
other Non-medical Therapies
David Halpin, UK
• Non-pharmacological therapies
• Pulmonary rehabilitation 11:00
• Interventional therapies
• Non-invasive ventilation
• Comorbidities
• COVID-19
COPD II - Precision Medicine in COPD:
Medical Treatment Standards
Claus Vogelmeier, Germany
• Morphine for dyspnea relief 11:45
• Pharmacotherapy and lung function decline
• Theophylline in stable COPD The Pneumo Update Europe 2021 has been accredited by the
• Withdrawal of ICS European Board for Accreditation in Pneumology (EBAP) for 9 CME
• Triple-therapy – mortality
credits and 9 European CME credits (ECMEC®s) by the European
Industry-sponsored Satellite Symposium 12:30 Accreditation Council for Continuing Medical Education (EACCME®)
Break 13:15 covering the scientific program.
Speakers
Prof. Christoph Lange Prof. Luca Richeldi
University of Luebeck University Hospital A. Gemelli
Research Center Borstel Catholic University of the Sacred Heart
German Center for Infection Research (DZIF)
Parkallee 35, 23845 Borstel (Germany) Largo Agostino Gemelli 8, 00167 Rome (Italy)
clange@fz-borstel.de luca.richeldi@policlinicogemelli.it
Prof. Johan Vansteenkiste Prof. Felix Herth
University Hospital KU Leuven University of Heidelberg
Respiratory Oncology and Clinical Trial Unit Thoraxklinik
Department of Pneumology Dept. of Pneumology and Critical Care Medicine
Herestraat 49, 3000 Leuven (Belgium) Roentgenstrasse 1, 69126 Heidelberg (Germany)
johan.vansteenkiste@uzleuven.be felix.herth@med.uni-heidelberg.de
Prof. Stephen Durham Prof. Paolo Pelosi
National Heart and Lung Institute University of Genoa
Imperial College London Department of Surgical Sciences and Integrated
Diagnostics
Dovehouse Street, London SW3 6LY (UK) L.go R. Benzi, 8-16132 Genoa (Italy)
s.durham@imperial.ac.uk ppelosi@hotmail.com
Prof. Roland Buhl Prof. Sally Singh
University Hospital Mainz University Hospitals of Leicester NHS Trust
Pulmonary Department Pulmonary and Cardiac Rehabilitation
Biomedical Research Centre – Respiratory
Glenfield Hospital
Langenbeckstrasse 1, 55131 Mainz (Germany) Groby Road, Leicester, LE3 9QP (UK)
roland.buhl@unimedizin-mainz.de sally.singh@uhl-tr.nhs.uk
Prof. Gilbert Massard Prof. Marc Humbert
University of Luxembourg University Paris-Saclay
Hôpitaux Robert Schuman Service de Pneumologie, Hôpital Bicêtre
2, Avenue de l‘Université, L-4365 Esch-sur-Alzette 78 rue du Général Leclerc,
(Luxembourg) 94270 Le Kremlin Bicêtre, Paris (France)
gilbert.massard@uni.lu marc.humbert@aphp.fr
Prof. David M.G. Halpin
Royal Devon and Exeter Hospital
Barrack Road, Exeter EX2 5DW (UK)
d.halpin@nhs.net
Prof. Claus Vogelmeier
Philipps-University of Marburg
Department of Medicine, Pulmonary and
Critical Care Medicine
View a selection of Pneumo Update Europe lectures
Baldingerstr., 35043 Marburg (Germany) on-demand, whereever and whenever you want –
claus.vogelmeier@med.uni-marburg.de free for delegates!
How it works:
Prof. Walter McNicholas • Register at www.streamed-up.com for free
University College Dublin • From the left-hand menu, choose European
St. Vincent‘s University Hospital Update Congresses
Dept. of Respiratory & Sleep Medicine
• Find the video that you want to see and enter the code:
Elm Park, Dublin 4 (Ireland) PneumoEurope21 (code is only accessible to 2021 delegates,
walter.mcnicholas@ucd.ie beginning Sept. 1, 2021)
Mini-Symposium at the Pneumo Update Europe 2021
Friday 25th June, 12:30–13:15
Livestream at streamed-up.com (and on-demand after the conference)
Sharing important insights:
What we learnt from COVID-19
Chair: Claus Vogelmeier, Germany 12:55–13:05 Pulmonary radiology for emphy-
12:30–12:35 Welcome and introduction sema in the COVID-19 era – when,
Claus Vogelmeier why and how?
12:35–12:45 Concomitant pulmonary diseases: Sebastian Ley
potential risk factors for COVID-19 13:05–13:15 Questions & summary
Luca Richeldi Claus Vogelmeier
12:45–12:55 Winners and losers:
managing chronically ill patients
during the pandemic
Joanna Chorostowska-Wynimko
Register for the livestream at https://www.streamed-up.com/pneumo-update-europe-2021-livestream/
CSL Behring-hosted symposium
©2021 Boehringer Ingelheim International GmbH. All rights reserved.
TURN... 1
Pneumo Update Europe
is supported by
Boehringer IngelheimUp to
...OPEN 1 52%
of COPD patients struggle to inhale,
...PRESS! 1
including patients with mild disease
disease.2*†‡
82%
of COPD patients eligible for
maintenance therapy experience
dyspnoea5
©2021 Boehringer Ingelheim International GmbH. All rights reserved.
1 SPIOLTO® RESPIMAT package insert leaflet
2 Loh CH et al. Ann Am Thorac Soc. 2017;14(8): 1305-1311.
3 Sharma G et al. Chronic Obstr Pulm Dis. 2017;4(3):217-224.
4 Barnes N et al. Chest. 2020 [Epub ahead of print] doi: 10.1016/j. chest.2020.03.072.
5 Müllerová H et al. PLoS One. 2014;9(1):e85540.
† Denotes patients with suboptimal peak inspiratory flow (sPIF), which is a measure of a patient’s inspiratory effort, or ability to inhale. In this study, suboptimal PIF was defined as ≤60 L/min.2,3
† Retrospective chart review of 123 patients hospitalised for acute exacerbation of COPD. Disease severity based upon GOLD classification; patients across all ranges of severity
were included.2 A retrospective analysis of hospitalised patients enrolled in an AECOPD care plan was performed. Data analysed included PIF, age, sex, length of stay, Charlson Comorbidity
Index, COPD Assessment Test Score, Modified Medical Research Council Score, percent predicted FEV1, FVC, and inspiratory capacity. A PIF ≤60 L/min was defined as suboptimal (sPIF).
Outcome measures included 30- and 90- day COPD and all-cause readmissions, and days to next COPD and allcause readmission. Of the 123 subjects, 52% had sPIF. PIF was the only variable
(p=0.041) that predicted days to COPD readmission in a multivariate model incorporating age, sex, percent predicted FEV1, Charlson Comorbidity Index, and inspiratory flow group.2
‡ sPIF has been observed in 19–78% of stable outpatients and 32–52% of inpatients before discharge from the hospital after treatment for COPD exacerbation.4An add-on maintenance treatment for patients (12+ years) with uncontrolled severe asthma with type 2 inflammation A CLEAR PATH TO ASTHMA CONTROL Join us for a live symposium on Friday, 25 June 2021 at 16:45 CEST Pneumology Meets Oto-Rhino-Laryngology: A Discussion of Type 2 Inflammation in Airway Diseases Visit the SANOFI GENZYME and REGENERON company page to discover more about the first and only asthma biologic to inhibit IL-4 and IL-13 signaling The content of this event is based on the EU SmPC, which can be accessed by clicking the link: https://www.ema.europa.eu/en/documents/product-information/dupixent-epar-product- information_en.pdf. Sanofi Genzyme and Regeneron do not recommend the use of their products in any manner inconsistent with that described in the label available in your country. Please refer to your local product labeling information before prescribing. © 2021 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved. 05/2021 MAT-GLB-2101738(V1)
Sponsored symposium
at the Pneumo Update Europe 2021
TYPE 2 INFLAMMATION:
New Developments in
Severe Asthma Management
Prof. Guy Brusselle and
Dr. Anneke ten Brinke
Saturday 26 June, 2021
12.30 CEST
Live virtual event
MAT-GLB-2102127 (V2)Useful Information
Registration includes: Save the date
9 th Pneumo Update Europe 2022
• Participation in all lectures and symposia
24 – 25 June 2022 Hybrid
• CME accreditation
• Presentations to download
• Free access to a selection of lectures as To stay updated follow us on twitter @medupdateeurope
video-on-demand beginning September 1, 2021 or visit our website: www.medupdate-europe.eu
• Free access to the livestream on-demand for
3 months after the event
Congress Host
med update europe GmbH
Congress Organisation Hagenauer Straße 53, D-65203 Wiesbaden, Germany
wikonect GmbH Phone: +49(0)611 9458799-0
Hagenauer Straße 53, D-65203 Wiesbaden, Germany Fax: +49(0)611 9458799-9
Phone: +49(0)611 949154-20, Fax: +49(0)611 949154-99 info@medupdate-europe.com
pneumo-update-europe@wikonect.de, www.wikonect.de www.medupdate-europe.eu
The following companies disclose their support in accordance with the FSA Code or with internal transparency rules: Boehringer Ingelheim Pharma GmbH & Co. KG, Novartis Pharma AG, Sanofi Genzyme, CSL
Behring and AstraZeneca. The support entitles companies to a mention on all promotional materials. For more details see www.pneumo-update-europe.eu. The sponsoring companies have no influence on the
content or program of the meeting.You can also read
